The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aclaris Therapeutics, Inc. COM 00461U105 8,816 1,362,612 SH   SOLE   1,362,612 0 0
Aeglea BioTherapeutics, Inc. COM 00773J103 6,955 883,720 SH   SOLE   883,720 0 0
Albireo Pharma, Inc. COM 01345P106 3,751 100,000 SH   SOLE   100,000 0 0
Allakos Inc COM 01671P100 20,476 146,259 SH   SOLE   146,259 0 0
Allovir, Inc COM 019818103 3,165 82,336 SH   SOLE   82,336 0 0
Alpine Immune Sciences Inc COM 02083G100 5,030 399,190 SH   SOLE   399,190 0 0
Amarin Corp PLC SPONS ADR NEW 023111206 122 25,000 SH   SOLE   25,000 0 0
Atreca Inc COM 04965G109 7,670 474,943 SH   SOLE   474,943 0 0
Avadel Pharmaceuticals PLC SPONS ADR 05337M104 2,901 434,250 SH   SOLE   434,250 0 0
BCLS Acquisition Corp COM G0904B105 3,342 300,000 SH   SOLE   300,000 0 0
BCTG Acquisition Corp COM 05492W103 5,720 500,000 SH   SOLE   500,000 0 0
BioNTech SE SPONS ADS 09075V102 880 10,795 SH   SOLE   10,795 0 0
Catabasis Pharmaceuticals Inc COM 14875P206 642 300,000 SH   SOLE   300,000 0 0
Chinook Therapeutics Inc COM 16961L106 50,251 3,168,388 SH   SOLE   3,168,388 0 0
Cogent Biosciences Inc COM 19240Q201 6,614 588,961 SH   SOLE   588,961 0 0
Consonance HFW Acquisition Co COM G2445M129 3,141 300,000 SH   SOLE   300,000 0 0
CureVac N.V. COM N2451R105 7,727 95,318 SH   SOLE   95,318 0 0
Equillium, Inc. COM 29446K106 5,747 1,074,285 SH   SOLE   1,074,285 0 0
Forma Therapeutics Holdings, Inc. COM 34633R104 49,507 1,418,529 SH   SOLE   1,418,529 0 0
Fulcrum Therapeutics, Inc. COM 359616109 3,444 294,118 SH   SOLE   294,118 0 0
Genron Corporation COM 374163103 1,948 1,224,870 SH   SOLE   1,224,870 0 0
Hookipa Pharma Inc COM 43906K100 1,438 129,660 SH   SOLE   129,660 0 0
Intercept Pharmaceuticals Inc COM 45845P108 9,971 403,688 SH   SOLE   403,688 0 0
Iveric Bio, Inc. COM 46583P102 16,396 2,372,476 SH   SOLE   2,372,476 0 0
Jiya Acquisition Corp COM 47760M102 507,041 5,223 SH   SOLE   5,223 0 0
Kadmon Hldgs Inc COM 48283N106 685 165,000 SH   SOLE   165,000 0 0
Kala Pharmaceuticals Inc COM 483119103 4,076 601,162 SH   SOLE   601,162 0 0
KalVista Pharmaceuticals Inc COM 483497103 1,277 67,270 SH   SOLE   67,270 0 0
Kronos Bio Inc COM 50107A104 4,966 166,250 SH   SOLE   166,250 0 0
Lifesci Acquisition II Corp COM 53229E103 2,134 200,000 SH   SOLE   200,000 0 0
NGM Biopharmaceuticals, Inc. COM 62921N105 552 18,225 SH   SOLE   18,225 0 0
Nkarta, Inc. COM 65487U108 125,073 2,034,703 SH   SOLE   2,034,703 0 0
Novavax, Inc. COM 670002401 3,363 30,160 SH   SOLE   30,160 0 0
Odonate Therapeutics Inc COM 676079106 15,656 815,421 SH   SOLE   815,421 0 0
Panacea Acquisition Corp. UNIT 698102209 5,104 400,000 SH   SOLE   400,000 0 0
Rhythm Pharmaceuticals Inc COM 76243J105 5,977 201,046 SH   SOLE   201,046 0 0
Rocket Pharmaceuticals Inc COM 77313F106 3,497 63,770 SH   SOLE   63,770 0 0
Silverback Therapeutics Inc COM 82835W108 1,159 25,000 SH   SOLE   25,000 0 0
Springworks Therapeutics Inc COM 85205L107 19,042 262,572 SH   SOLE   262,572 0 0
Sutro BioPharma Inc COM 869367102 36,377 1,675,579 SH   SOLE   1,675,579 0 0
Syros Pharmaceuticals Inc COM 87184Q107 21,837 2,189,199 SH   SOLE   2,189,199 0 0
Vistagen Therapeutics Inc COM 92840H202 3,182 1,640,368 SH   SOLE   1,640,368 0 0
Verona Pharma PLC. SPONS ADS 925050106 7,778 1,111,112 SH   SOLE   1,111,112 0 0